本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

108.88
+0.81000.75%
盘前108.38-0.5000-0.46%07:33 EDT
成交量:8.46万
成交额:917.02万
市值:20.97亿
市盈率:-493.90
高:109.31
开:108.04
低:106.96
收:108.07
数据加载中...
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/28

重要事件披露

8-K - Current report
2021/01/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/21

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/10

重要事件披露

8-K/A [Amend] - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/23

重要事件披露

8-K - Current report
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]